Top compounds associated with response to CTC-360G5.8


Feature Type Standardized
Nominal ANOVA
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.028 0.4
mRNA BEC CTRPv2 pan-cancer AAC -0.057 0.4
mRNA pifithrin-alpha CTRPv2 pan-cancer AAC 0.029 0.4
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.027 0.4
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.028 0.4
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.029 0.4
mRNA JQ-1:vorinostat (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.026 0.4
mRNA quizartinib CTRPv2 pan-cancer AAC 0.029 0.4
mRNA L-685458 CTRPv2 pan-cancer AAC -0.028 0.4
mRNA ML203 CTRPv2 pan-cancer AAC -0.029 0.5
Download CSV